Cure8 research brief
Why This Matters
The study links changes in gut microbes and microbial functions with disease activity in children with IBD, suggesting the microbiome may play a role in recovery and could be a target to help sustain remission.
Who Should Pay Attention
Pediatric patients and caregivers, pediatric IBD clinicians, and microbiome researchers.
Study Snapshot
What To Know
This paper describes intra-individual microbiome shifts between active disease and remission in seven children (five with Crohn's, two with ulcerative colitis).
Remission samples showed more of several taxa often considered beneficial (for example, Bifidobacterium spp., Faecalibacterium prausnitzii, Anaerostipes hadrus) and functional genes linked to metabolic and biosynthetic pathways; flare samples had higher Klebsiella pneumoniae.
The authors suggest these changes could support barrier integrity and tissue repair and discuss targeted microbiome modulation as a possible strategy to help maintain remission. The findings are preliminary and from a small pilot cohort at a single center in Singapore.
They illustrate biological signals that merit validation in larger, multi-center pediatric studies before changing clinical care.
Keep In Mind
Small single-center pilot study (n=7 paired samples). Findings are exploratory and require validation before clinical application. Summary is grounded in the article abstract.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.